A landscape on disorders following different COVID-19 vaccination: a systematic review of Iranian case reports
M Sadat Larijani, D Doroud, M Banifazl… - European Journal of …, 2023 - Springer
There have been massive studies to develop an effective vaccine against SARS-CoV-2
which fortunately led to manage the recent pandemic, COVID-19. According to the quite …
which fortunately led to manage the recent pandemic, COVID-19. According to the quite …
COVID‐19 vaccine–associated vitiligo: a cross‐sectional study in a tertiary referral center and systematic review
TF Tsai, CY Ng - The Journal of Dermatology, 2023 - Wiley Online Library
As the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus continues to
infect patients globally, vaccination remains one of the primary methods to combat this …
infect patients globally, vaccination remains one of the primary methods to combat this …
Effect of COVID-19 vaccines on hair loss
MG Yousif, D Al-Jumeily… - Health Education …, 2023 - researchonline.ljmu.ac.uk
Aims: The COVID-19 pandemic has led to the global distribution of vaccines, but there are
concerns regarding potential side effects. Hair loss is one of the less commonly reported …
concerns regarding potential side effects. Hair loss is one of the less commonly reported …
Global burden of vaccine-associated alopecia, 1979–2023: a comprehensive analysis of the international pharmacovigilance database
While global concern over vaccine-associated alopecia has been gradually increasing, it
has also been reported that alopecia, classified as an autoimmune disease, can manifest as …
has also been reported that alopecia, classified as an autoimmune disease, can manifest as …
A case series and literature review of telogen effluvium and alopecia universalis after the administration of a heterologous COVID-19 vaccine scheme
J Hernández Arroyo, JS Izquierdo-Condoy… - Vaccines, 2023 - mdpi.com
COVID-19 vaccines have positively changed the course of the pandemic. They entered the
market after only one year of the initial trials, which that yielded positive results in terms of …
market after only one year of the initial trials, which that yielded positive results in terms of …
[HTML][HTML] Recent advances in understanding of the etiopathogenesis, diagnosis, and Management of Hair Loss Diseases
M Kinoshita-Ise, M Fukuyama, M Ohyama - Journal of Clinical Medicine, 2023 - mdpi.com
Hair-loss diseases comprise heterogenous conditions with respective pathophysiology and
clinicopathological characteristics. Major breakthroughs in hair follicle biology and …
clinicopathological characteristics. Major breakthroughs in hair follicle biology and …
The correlation between corona virus disease 2019 and alopecia areata: a literature review
Y Xie, S Lv, S Luo, Y Chen, M Du, Y Xu… - Frontiers in …, 2024 - frontiersin.org
Corona virus disease 2019 (COVID-19) is one of the most serious respiratory pandemic
diseases threatening human health for centuries. Alopecia areata (AA) is a sudden patchy …
diseases threatening human health for centuries. Alopecia areata (AA) is a sudden patchy …
Alopecia areata following COVID-19 vaccine: a systematic review
Y Zhu, X Ouyang, D Zhang, X Wang, L Wu, S Yu… - European Journal of …, 2024 - Springer
Background To date, multiple cases of adverse reactions to COVID-19 vaccines have been
reported worldwide. Alopecia areata (AA) is an uncommon type of adverse reaction reported …
reported worldwide. Alopecia areata (AA) is an uncommon type of adverse reaction reported …
[HTML][HTML] The Incidence of Alopecia Areata in a COVID-19-Vaccinated Population: A Single-Center Review
J Chen, S Cano-Besquet, H Ghantarchyan, MM Neeki - Cureus, 2023 - ncbi.nlm.nih.gov
Background Cases of alopecia areata (AA) attributed to the coronavirus disease 2019
(COVID-19) vaccination have been reported in recent literature. However, these reports are …
(COVID-19) vaccination have been reported in recent literature. However, these reports are …
Cutaneous Reactions to COVID-19 mRNA Vaccines
AG Strahan, EE Freeman - COVID-19 in Dermatology, 2023 - Springer
Abstract mRNA vaccines emerged as a crucial tool to target the rapid spread and reduce
morbidity and mortality secondary to SARS-CoV-2. Rollout of mRNA vaccines worldwide …
morbidity and mortality secondary to SARS-CoV-2. Rollout of mRNA vaccines worldwide …